| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/03/2002 | CN1342658A Polypeptide-PO protein 26.07 and polynucleotide for coding it |
| 04/03/2002 | CN1082091C Recombination human tumour necrofactor and preparation method |
| 04/03/2002 | CN1082043C Novel cationic lipids and the use thereof |
| 04/03/2002 | CA2358380A1 Testis-specific gene |
| 04/02/2002 | USH2019 Identifying compounds that bind and/or inhibit the hi1648 protein. |
| 04/02/2002 | US6366860 Synthetic genes for enhanced expression |
| 04/02/2002 | US6365798 Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production |
| 04/02/2002 | US6365796 Transgenic UCP2 knockout mouse and use thereof |
| 04/02/2002 | US6365728 Regulatory element for expressing genes in plants |
| 04/02/2002 | US6365726 Polynucleotides encoding IL-1 Hy2 polypeptides |
| 04/02/2002 | US6365725 DNA coding for a human vasoconstrictive peptide and use thereof |
| 04/02/2002 | US6365723 Nucleotide sequences; diagnosis of infections; bactericides |
| 04/02/2002 | US6365722 Nucleic acid encoding an i-kappa-b kinase binding protein of defined amino acid sequence; antinflammatory agents; immunosuppressants |
| 04/02/2002 | US6365717 Peptides and nucleic acid sequences related to the Epstein Barr virus |
| 04/02/2002 | US6365716 Binds to epitope of polypeptide having defined amino acid sequence; antitumor agents |
| 04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
| 04/02/2002 | US6365714 Amino acid sequence of a polypeptide; antiinflammatory agents; antiproliferative agents; antiapoptotic agents |
| 04/02/2002 | US6365713 Low density lipoprotein receptor produced in culture; viricides |
| 04/02/2002 | US6365712 Isolated soluble cd antigen; diagnosis and treatment of related disorders |
| 04/02/2002 | US6365711 Methods and reagents for modulating TGF-β superfamily signalling |
| 04/02/2002 | US6365572 For therapy of diseases related to increased or unwanted synthesis of basement membranes such as diabetes mellitus; atherosclerosis; cancer; diabetic retinopathia; fibroplasia retrolentalis; or psoriasis, rheumatoic arthritis |
| 04/02/2002 | US6365570 Administering in unit dosage form of a peptide comprising serum amyloid p component or at least one endotoxin-binding fragment thereof, effective to neutralize lipopolysaccharide in an animal or patient thus treated |
| 04/02/2002 | US6365569 To protect animals from diseases caused by parasitic helminths |
| 04/02/2002 | US6365410 Culturing microorganism with a heterologous mutator gene having an increased mutation rate for at least 20 doublings under selective conditions, then restoring resultant microorganism to wild type mutation rate; biosynthesis |
| 04/02/2002 | US6365409 Regulated gene expression in yeast |
| 04/02/2002 | US6365403 High-efficiency AAV helper functions |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365401 Nucleotide sequences in a vector; for development of vaccines and viricides |
| 04/02/2002 | US6365396 Parasite-derived resistance |
| 04/02/2002 | US6365394 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/02/2002 | US6365393 Recombinant virus with an insertion in the hind iii fragment i region; immunomodulators |
| 04/02/2002 | US6365392 Amino acid sequences; anthelmintics; nematocides; vaccines; for veterinary medicine |
| 04/02/2002 | US6365387 fabG |
| 04/02/2002 | US6365379 Zinc finger peptide cleavage of nucleic acids |
| 04/02/2002 | US6365373 Which have tyrosine kinase receptor c (trkc)-binding activity and trkc-signal inducing activity; nucleic acids, expression vectors, host cells; treating diabetic peripheral neuropathy |
| 04/02/2002 | US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents |
| 04/02/2002 | US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others |
| 04/02/2002 | US6365369 Polynucleotide which encodes a specific amino acid sequence; diagnosis and therapy of urogenital disorders |
| 04/02/2002 | US6365360 Methods of identifying modulators of human IP prostaglandin receptor |
| 04/02/2002 | US6365359 Identifying prp pharmacore by determining functional residues of protein involved in complex interactions, developing three dimensional structures, comparing them with other compounds and identifying compounds consistent with binding to protein |
| 04/02/2002 | US6365356 Receptors that regulate cell signaling relating to chemokines |
| 04/02/2002 | US6365348 Obtaining biological sample, generating cdna, contacting with oligonucleotide primers of defined nucleotide sequence in polymerase chain reaction, detecting amount of cdna sequence that amplifies; using predetermined cut-off value |
| 04/02/2002 | US6365342 Methods for detecting anti-viral activity of calcium-dependent lectins |
| 04/02/2002 | US6365337 Genes encoding neuronal voltage-gated calcium channel gamma subunits |
| 04/02/2002 | US6365165 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
| 04/02/2002 | US6365161 Molecular complex comprising two or more protein or peptide binding specificities for component on surface of antigen presenting cell, having at least one antigen linked thereto, wherein component mediates internalization of complex |
| 04/02/2002 | US6365160 Polyprotein construct comprising amino acid sequences fused directly or indirectly together, each being sequence of early open reading frame protein of papillomavirus, or immunogenic variant or non-full length deletion mutant thereof |
| 04/02/2002 | US6365159 Spo-rel |
| 04/02/2002 | US6365158 Immunizing avian host with purified recombinant fusion protein comprising non-toxin protein sequence and portion of clostridium difficile toxin b sequence so as to generate neutralizing antitoxin |
| 04/02/2002 | US6365157 Angiogenesis inhibitors; antitumor agents |
| 04/02/2002 | US6365151 Transfection; genetic engineering |
| 04/02/2002 | US6365127 Isolation of a gene encoding human thyrotropin beta subunit |
| 04/02/2002 | CA2359465A1 The application of bi-directional promoters for modification of gene expression |
| 04/02/2002 | CA2252664C Method and apparatus for data transmission using multiple transmit antennas |
| 04/02/2002 | CA2222914C Novel cd40l mutein |
| 04/02/2002 | CA2182483C Il-3 variant hematopoiesis fusion protein |
| 04/02/2002 | CA2147875C Crf binding protein |
| 04/02/2002 | CA2086835C Tissue plasminogen activator variants with decreased clearance |
| 04/02/2002 | CA1341354C Anticoagulant peptide alcohols |
| 04/02/2002 | CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody |
| 03/29/2002 | CA2340303A1 Rna-binding protein |
| 03/28/2002 | WO2002025285A1 Prognostic indicator |
| 03/28/2002 | WO2002025284A2 High-throughput assays for the proteolytic activities of clostridial neurotoxins |
| 03/28/2002 | WO2002025276A1 Crystal structure of bace and uses thereof |
| 03/28/2002 | WO2002025270A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 03/28/2002 | WO2002024951A1 Haplotypes of the il1b gene |
| 03/28/2002 | WO2002024943A2 Method of identifying osteoregenerative agents using differential gene expression |
| 03/28/2002 | WO2002024940A2 Means for the identification of compounds capable of inhibiting karap-transduced signals |
| 03/28/2002 | WO2002024936A1 Process for the fermentative preparation of d-pantothenic acid using coryneform bacteria |
| 03/28/2002 | WO2002024929A2 A SOLUBLE BETA 2 MICROGLOBULIN (β2M)/HFE MONOCHAIN FOR BIOTECHNOLOGICAL AND THERAPEUTIC APPLICATIONS |
| 03/28/2002 | WO2002024927A2 Regulation of human adam-ts 1 precursor-like protein |
| 03/28/2002 | WO2002024916A1 Complex |
| 03/28/2002 | WO2002024915A1 Dcta (c4-dicarboxylate transporter) from corynebacterium glutamicum |
| 03/28/2002 | WO2002024914A1 Modification of plant cell wall component and method of regulating development differentiation |
| 03/28/2002 | WO2002024913A2 32612, a novel human peptide transporter and uses therefor |
| 03/28/2002 | WO2002024912A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | WO2002024911A2 63760, a novel human transporter and uses thereof |
| 03/28/2002 | WO2002024910A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024909A2 Receptor nucleic acids and polypeptides |
| 03/28/2002 | WO2002024908A1 Novel tissue-specific secretory polypeptide and dna thereof |
| 03/28/2002 | WO2002024907A2 G-protein coupled receptor hfrbn63 |
| 03/28/2002 | WO2002024903A1 Method of examining allergic disease |
| 03/28/2002 | WO2002024896A2 Screening assays for agonists or antagonists of receptor activat or of nf-kb |
| 03/28/2002 | WO2002024895A2 Transcription factors and zinc finger proteins |
| 03/28/2002 | WO2002024894A2 Human protease inhibitor proteins and polynucleotides encod ing the same |
| 03/28/2002 | WO2002024892A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024890A2 Rice mlh1 ortholog and uses thereof |
| 03/28/2002 | WO2002024888A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/28/2002 | WO2002024887A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 03/28/2002 | WO2002024885A2 Regulation of human g protein-coupled receptor |
| 03/28/2002 | WO2002024883A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 03/28/2002 | WO2002024880A1 Nucleotide sequences which code for the ndka gene |
| 03/28/2002 | WO2002024879A2 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 03/28/2002 | WO2002024871A1 Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies |
| 03/28/2002 | WO2002024869A2 Elicitor of fungal origin and method for its preparation |
| 03/28/2002 | WO2002024868A2 Non-human model of gestational and adult folate deficiency and uses thereof |
| 03/28/2002 | WO2002024867A2 Novel compositions and methods for lymphoma and leukemia |
| 03/28/2002 | WO2002024751A1 Dextran-hemoglobin conjugates as blood substitutes |
| 03/28/2002 | WO2002024750A2 Human kidney tumor overexpressed membrane protein 1 |